C Cu ut ta an ne eo ou us s d dr ru ug g e er ru up pt ti io on ns s i in n c ch hi il ld dr re en n; ; a a s si in ng gl le e c ce en nt tr re e e ex xp pe er ri ie en nc ce e S Se er ra ap p Ö Öz zm me en n, , M Mu ur ra at t fi fia ah hi in n* *, , A Ay ys se el l Y Yö ön ne ey y* *, , N Ni il lü üf fe er r A Ar rd da a* *, , Z Za af fe er r A Ar rs sl la an n O Or ri ig gi in na al l A Ar rt ti ic cl le e S Su um mm ma ar ry y Aim: Cutaneous drug reactions are commonly reported adverse drug reactions. The aim of this study was to describe the clinical pattern of drug eruptions, determine drugs commonly associated with those patterns seen among children and to suggest an approach to this problem. One hundred children were enrolled in the study, There were 75 boys and 25 girls with an age range of 6 months to 14 years old (mean 5.6±3.6 years). Statistical analyses were done using SPSS 11.5 package program (SPSS Inc., Chiago, IL). For general information related to variants descriptive statistics and frequency distributions were calculated. While continuously measured variables were shown as mean± SD, categorical variables were expressed as frequency (percentage). The study was approved by the hospital's ethic committee.
Material andResults:The most common indication for using drug therapy was upper respiratory tract infection (64%). The most commonly suspected drugs were amoxicillin/ampicillin in 44% and cephalosporins in 27% of the patients. The types of drug eruption included urticaria (64%), maculopapular eruption (28%), urticaria-purpura (5%), erythema multiforme (1%), fixed drug eruption (1%) and drug hypersensitivity syndrome (1%). While 60% of the patients were diagnosed with probable drug allergy and %16 were diagnosed with possible drug allergy, drug allergy was confirmed only in 18% of the patients who were diagnosed with definite drug allergy.
Conclusions:A detailed drug history, a knowledge of the varied patterns of drug eruptions and appropiate diagnostic tests are essential factors for successful management of a child with drug eruption (Turk Arch Ped 2011; 46: 62-6)